Portfolio comparison
Sangamo Therapeutics vs Merck Sharp and Dohme LLC
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Sangamo Therapeutics
Patents indexed
1
Year range
2023
Most recent
2023
biotechgene_editingpharmaceuticalsoftware
Top Patents1 enriched
US 11661612· 2023
How Engineered TALE Proteins Can Edit Genes
Activity by Decade
2020s1
Company B
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.